Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
6.84
-0.42 (-5.72%)
At close: Apr 1, 2026, 4:00 PM EDT
6.98
+0.15 (2.12%)
After-hours: Apr 1, 2026, 4:09 PM EDT

Wave Life Sciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
602.07302.08200.3588.5150.56
Cash & Short-Term Investments
602.07302.08200.3588.5150.56
Cash Growth
99.31%50.77%126.39%-41.22%-18.39%
Accounts Receivable
1.281.4221.09--
Other Current Assets
11.4716.8913.9410.0412
Total Current Assets
614.81320.39235.3798.54162.56
Net Property, Plant & Equipment
19.862835.7244.1340.64
Other Long-Term Assets
3.823.823.863.723.8
Total Assets
638.5352.21274.95146.39207.01
Accounts Payable
15.716.2612.8416.927.28
Accrued Expenses
26.5621.0816.8317.5514.86
Current Portion of Leases
8.367.646.715.54.96
Unearned Revenue
44.4465.97150.0631.5637.1
Total Current Liabilities
95.07110.95186.4471.5264.2
Long-Term Leases
9.4117.7725.432.1224.96
Other Long-Term Liabilities
7.86.115.679.9677.48
Total Long-Term Liabilities
17.223.8741.01112.08102.43
Total Liabilities
112.27134.82227.45183.6166.64
Common Stock
1,6161,175935.37802.83749.85
Additional Paid-in Capital
228.37156.45129.24119.4487.98
Accumulated Other Comprehensive Income
-0.25-0.26-0.12-0.030.18
Retained Earnings
-1,326-1,122-1,025-967.34-805.51
Total Common Shareholders' Equity
518.36209.5239.63-45.0932.5
Minority Interest
7.877.877.877.877.87
Shareholders' Equity
526.23217.3947.5-37.2240.37
Total Liabilities & Equity
638.5352.21274.95146.39207.01
Total Debt
17.7725.432.1237.6129.92
Net Cash (Debt)
584.3276.67168.2350.88120.65
Net Cash Growth
111.19%64.46%230.63%-57.83%-22.26%
Net Cash Per Share
3.462.001.590.652.33
Book Value
518.36209.5239.63-45.0932.5
Book Value Per Share
3.071.520.37-0.570.63
Tangible Book Value
518.36209.5239.63-45.0932.5
Tangible Book Value Per Share
3.071.520.37-0.570.63
Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q